Background: Mortality rates remain higher in HIV positive than HIV negative individuals despite the introduction of antiretroviral therapy (ART). Understanding the causes of death in HIV positive individuals, and how these have altered with ART treatment, will help direct interventions to prevent these deaths. Since causes of death are not medically certified in sub-Saharan Africa we rely on interpretation of verbal autopsy data to generate cause of death information.
Methods: We used verbal autopsy data collected in three community-based HIV cohorts from Tanzania (Kisesa), Malawi (Karonga) and South Africa (uMkhanyakude), which form part of the ALPHA network. Data on symptoms and circumstances were processed using the InSilicoVA algorithm, and cause of death distributions were classified by ART availability and HIV status of the deceased. The percentage of deaths assigned to HIV/AIDS using the algorithm were compared to age-standardized HIV attributable mortality. HIV attributable mortality (PAF) was calculated by comparing the observed numbers of deaths in HIV positive individuals to the number expected if age-specific mortality rates were the same as those observed in the HIV negative group.
Results: Following ART introduction, there were substantial declines in the percentage of deaths assigned to HIV/AIDS. The most dramatic declines were observed in Kisesa, where the percentage of deaths assigned to HIV/AIDS dropped from 43% in the pre-ART era to 26% once ART became widely available, compared to a decline from 36% to 32% in the PAF. Amongst HIV positive individuals in Kisesa the percentage of deaths assigned to TB increased with ART availability for both males (from 26.3% to 36.3%) and females (from 27.9% to 33.9%); neoplasms increased in females (from 4.3% to 10.1%) but not males where they remained at 8.0%. In uMkhanyakude there was a large increase in the percentage of HIV positive female deaths assigned to TB (from 24.8% to 36.5%) but no such trend was observed in males. There were no substantial changes in the percentage of deaths attributed to non-communicable diseases in uMkhanyakude.
Conclusions: Increases in the percentage of deaths from neoplasms among the HIV positive are to be expected as deaths from classic HIV-related causes are suppressed by ART. The fact that TB continues to rise as a proportion of all assigned causes among the HIV-positive suggests better management of TB cases is needed at treatment start.